GOG-0274 RTOG 1174
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: THE OUTBACK TRIAL
Principal Investigator
Status
Terminated
Date Opened To Accrual
January 9, 2012
Date Closed To Accrual
June 28, 2017
Date of Study Termination
July 19, 2024
Disease Site
Gynecologic [GY] Cervix
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if the addition of adjuvant chemotherapy to standard cisplatin-based chemo-radiation improves overall survival.
Patient Population
Patients with stage IB1 & positive nodes, IB2, II, IIIB or IVA cervical cancer suitable for primary treatment with chemo-radiation with curative intent.
Target Accrual
500
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
